3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
2
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
172
fludarabine phosphate
132
Tacrolimus
100
Mycophenolic Acid
92
fludarabine
90
Busulfan
88
Whole-Body Irradiation
83
Peripheral Blood Stem Cell Transplantation
77
Antilymphocyte Serum
71
Melphalan
69
Filgrastim
63
Cyclosporine
62
Methotrexate
54
Radiotherapy
40
Thiotepa
39
Cord Blood Stem Cell Transplantation
35
Granulocyte Colony-Stimulating Factor
34
Stem Cell Transplantation
32
thymoglobulin
29
Sirolimus
27
Methylprednisolone
26
Rituximab
24
Cytarabine
23
Clofarabine
23
Etoposide
22
Alemtuzumab
20
Azacitidine
17
Specimen Handling
14
Cyclosporins
13
sargramostim
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Molecular Diagnostic Techniques
×
Lymphoid
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled